Viewing Study NCT06814158


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2025-12-25 @ 10:16 PM
Study NCT ID: NCT06814158
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-02-07
First Post: 2025-02-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module